Related Experiment Video
Updated: May 27, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Patients re-engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histoplasmosis and
Narda Medina1, Ana Alastruey-Izquierdo2,3, Oscar Bonilla4
1Asociación de Salud Integral, Guatemala City, Guatemala.
Insights
Patients re-engaging in care after HIV treatment interruption face high rates of advanced HIV disease and opportunistic infections like tuberculosis and histoplasmosis. Routine CD4 testing is crucial for early detection and intervention.
Area of Science:
- Infectious Diseases
- Public Health
- Immunology
Background:
- Antiretroviral therapy (ART) discontinuation contributes to advanced HIV disease (AHD) and opportunistic infections.
- This study examines patients re-engaging in care after ART interruption, comparing them to newly diagnosed HIV patients.
Purpose of the Study:
- To analyze the burden of tuberculosis and histoplasmosis in patients re-engaging in care versus newly diagnosed HIV patients.
- To highlight the need for timely CD4 testing and comprehensive diagnostics for advanced HIV disease.
Main Methods:
- A diagnostic package for opportunistic infections (tuberculosis, histoplasmosis) was implemented in Guatemala (2017-2019).
- 1379 adults re-engaging in care and 3412 newly diagnosed HIV patients were enrolled across 13 facilities.
- Data included demographics, lab results, and outcomes.
Main Results:
- AHD prevalence was high in both groups: 54% in re-engaging patients and 50.1% in newly diagnosed patients.
- Significant CD4 testing gaps existed: 34.5% un-tested in re-engaging vs. 21.1% in newly diagnosed.
- Incidence rates for tuberculosis and histoplasmosis were high in re-engaging patients (9.7% and 8.3%) and similar to newly diagnosed patients.
Conclusions:
- Patients re-engaging in care require similar diagnostic and care pathways as newly diagnosed individuals.
- Routine, immediate CD4 testing is essential to identify AHD and guide treatment.
- Early detection and targeted interventions are critical to reduce AIDS-related mortality.
Background:
Discontinuation of antiretroviral therapy (ART) significantly contributes to the development of advanced HIV disease (AHD) and opportunistic infections. This study analyzed data from patients who re-engaged in care after ART interruption and compared the cohort with patients with newly diagnosed HIV, focusing on the burden of tuberculosis and histoplasmosis.
Methods:
A diagnostic package for opportunistic infections was implemented in Guatemala in 2017, encompassing tuberculosis and histoplasmosis. From 2017 to 2019, we enrolled 1379 adults re-engaging in care and 3412 patients with newly diagnosed HIV across 13 healthcare facilities. Data collection included demographic information, laboratory test results, and patient outcomes.
Results:
Among patients re-engaging in care, 54% (491 of 903) had AHD, which was comparable to the 50.1% (1349 of 2692) in newly diagnosed patients. Among the re-engaging cohort, 34.5% had not undergone CD4 testing, compared with 21.1% in the newly diagnosed group. This highlights a significant gap in assessing advanced HIV status through an objective, unbiased test. Among patients re-engaging in care, the incidence rates of tuberculosis and histoplasmosis were 9.7% and 8.3%, respectively, regardless of immune status. This indicated a high burden of opportunistic infections in this group, with newly diagnosed patients showing similar incidence rates of 8.5% for tuberculosis and 8.3% for histoplasmosis.
Conclusion:
Patients re-engaging in care should follow a similar process to newly diagnosed patients. There is an urgent need for routine and immediate CD4 testing to identify AHD and implement the recommended comprehensive diagnostic and care package. Early detection and targeted interventions are crucial for reducing AIDS-related mortality.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles

